Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Exercise(A) | 2024-02-12 5:47 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 3,333 | $0 | 35,253 (Direct) | View |
| 2022-03-25 Option Award(A) | 2024-02-12 5:43 pm | N/A 2032-03-25 | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 7:05 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 12,000 | $0 | 45,252 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 7:05 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 3,333 | $0 | 45,252 (Direct) | View |
| 2023-09-07 Option Award | 2023-09-08 3:41 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 7,500 | $0 | 7,500 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 1:05 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 48,000 | $0 | 48,000 (Direct) | View |
| 2022-03-25 Option Award | 2022-03-29 7:14 pm | N/A 2032-03-24 | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2022-03-29 7:11 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 0 | $0 | 41,920 (Direct) | View |